TY - JOUR
T1 - Robotic Cardiac Surgery in Europe
T2 - Status 2020
AU - Cerny, Stepan
AU - Oosterlinck, Wouter
AU - Onan, Burak
AU - Singh, Sandeep
AU - Segers, Patrique
AU - Bolcal, Cengiz
AU - Alhan, Cem
AU - Navarra, Emiliano
AU - Pettinari, Matteo
AU - Van Praet, Frank
AU - De Praetere, Herbert
AU - Vojacek, Jan
AU - Cebotaru, Theodor
AU - Modi, Paul
AU - Doguet, Fabien
AU - Franke, Ulrich
AU - Ouda, Ahmed
AU - Melly, Ludovic
AU - Malapert, Ghislain
AU - Labrousse, Louis
AU - Gianoli, Monica
AU - Agnino, Alfonso
AU - Philipsen, Tine
AU - Jansens, Jean-Luc
AU - Folliguet, Thierry
AU - Palmen, Meindert
AU - Pereda, Daniel
AU - Musumeci, Francesco
AU - Suwalski, Piotr
AU - Cathenis, Koen
AU - Van den Eynde, Jef
AU - Bonatti, Johannes
N1 - Funding Information:
We would like to thank the European Association of Cardio-Thoracic Surgery (EACTS) for their continuing support in the development and implementation of robotic techniques in cardiac surgery across Europe. JVdE was supported by a Fellowship of the Belgian American Educational Foundation.
Publisher Copyright:
Copyright © 2022 Cerny, Oosterlinck, Onan, Singh, Segers, Bolcal, Alhan, Navarra, Pettinari, Van Praet, De Praetere, Vojacek, Cebotaru, Modi, Doguet, Franke, Ouda, Melly, Malapert, Labrousse, Gianoli, Agnino, Philipsen, Jansens, Folliguet, Palmen, Pereda, Musumeci, Suwalski, Cathenis, Van den Eynde and Bonatti.
PY - 2022/1/20
Y1 - 2022/1/20
N2 - Background: European surgeons were the first worldwide to use robotic techniques in cardiac surgery and major steps in procedure development were taken in Europe. After a hype in the early 2000s case numbers decreased but due to technological improvements renewed interest can be noted. We assessed the current activities and outcomes in robotically assisted cardiac surgery on the European continent.Methods: Data were collected in an international anonymized registry of 26 European centers with a robotic cardiac surgery program.Results: During a 4-year period (2016-2019), 2,563 procedures were carried out [30.0% female, 58.5 (15.4) years old, EuroSCORE II 1.56 (1.74)], including robotically assisted coronary bypass grafting (n = 1266, 49.4%), robotic mitral or tricuspid valve surgery (n = 945, 36.9%), isolated atrial septal defect closure (n = 225, 8.8%), left atrial myxoma resection (n = 54, 2.1%), and other procedures (n = 73, 2.8%). The number of procedures doubled during the study period (from n = 435 in 2016 to n = 923 in 2019). The mean cardiopulmonary bypass time in pump assisted cases was 148.6 (63.5) min and the myocardial ischemic time was 88.7 (46.1) min. Conversion to larger thoracic incisions was required in 56 cases (2.2%). Perioperative rates of revision for bleeding, stroke, and mortality were 56 (2.2%), 6 (0.2 %), and 27 (1.1%), respectively. Median postoperative hospital length of stay was 6.6 (6.6) days.Conclusion: Robotic cardiac surgery case numbers in Europe are growing fast, including a large spectrum of procedures. Conversion rates are low and clinical outcomes are favorable, indicating safe conduct of these high-tech minimally invasive procedures.
AB - Background: European surgeons were the first worldwide to use robotic techniques in cardiac surgery and major steps in procedure development were taken in Europe. After a hype in the early 2000s case numbers decreased but due to technological improvements renewed interest can be noted. We assessed the current activities and outcomes in robotically assisted cardiac surgery on the European continent.Methods: Data were collected in an international anonymized registry of 26 European centers with a robotic cardiac surgery program.Results: During a 4-year period (2016-2019), 2,563 procedures were carried out [30.0% female, 58.5 (15.4) years old, EuroSCORE II 1.56 (1.74)], including robotically assisted coronary bypass grafting (n = 1266, 49.4%), robotic mitral or tricuspid valve surgery (n = 945, 36.9%), isolated atrial septal defect closure (n = 225, 8.8%), left atrial myxoma resection (n = 54, 2.1%), and other procedures (n = 73, 2.8%). The number of procedures doubled during the study period (from n = 435 in 2016 to n = 923 in 2019). The mean cardiopulmonary bypass time in pump assisted cases was 148.6 (63.5) min and the myocardial ischemic time was 88.7 (46.1) min. Conversion to larger thoracic incisions was required in 56 cases (2.2%). Perioperative rates of revision for bleeding, stroke, and mortality were 56 (2.2%), 6 (0.2 %), and 27 (1.1%), respectively. Median postoperative hospital length of stay was 6.6 (6.6) days.Conclusion: Robotic cardiac surgery case numbers in Europe are growing fast, including a large spectrum of procedures. Conversion rates are low and clinical outcomes are favorable, indicating safe conduct of these high-tech minimally invasive procedures.
KW - cardiac surgery
KW - coronary artery bypass grafting
KW - keyhole surgery
KW - minimally invasive surgery
KW - mitral valve surgery
KW - robotic surgery
UR - http://www.scopus.com/inward/record.url?scp=85132895012&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2021.827515
DO - 10.3389/fcvm.2021.827515
M3 - Article
C2 - 35127877
SN - 2297-055X
VL - 8
SP - 1
EP - 11
JO - Frontiers in cardiovascular medicine
JF - Frontiers in cardiovascular medicine
M1 - 827515
ER -